Devices › Device types
FDA product code NAD · class 1 · General, Plastic Surgery
Dressing, wound, occlusive: medical device reports filed with FDA
18,954 reports carry this product code, 2004–2026; 9 brands with a page.
- 18,954
- reports with this product code
- 0.1% of all MAUDE reports
- 5,587
- reports, 12 months to August 2026
- 2,623 in the 12 months before
- 95.1%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code NAD is FDA's classification for "Dressing, wound, occlusive" (general, Plastic Surgery panel), a class 1 device. 18,954 medical device reports carry this product code, 0.1% of the MAUDE database, from January 2004 to August 2026.
5,587 reports arrived in the 12 months to August 2026, up 113% from 2,623 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.1%), injury (4.8%) and other (0.1%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Duoderm | 10,757 | 5,527 | 0% | 100% |
| Duoderm/Granuflex/Duoactive - Moisture Retentive Duoderm Cgf Dressing | 6,189 | 0 | 0% | 99.8% |
| L3w0750 - Duoderm | 293 | 0 | 0% | 98.6% |
| Aquacel Foam | 12 | 124 | 0% | 88.1% |
| Equate | 3 | 37 | 0.3% | 24% |
| Iv3000 1 Hand 6x7cm Ctn 100 | 3 | 3 | 0% | 93.6% |
| Opsite Flexifix Gentle 5cmx5m | 2 | 0 | 0% | 97.6% |
| EnCor Biopsy Probe | 1 | 15 | 0% | 99% |
| Renasys Go Npwt Device | 1 | 0 | 0% | 86.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Convatec Dominican Republic | 16,842 | 88.9% |
| Smith & Nephew Medical | 752 | 4% |
| Convatec | 406 | 2.1% |
| 3m Health Care | 72 | 0.4% |
| 3m | 23 | 0.1% |
| Integra Lifesciences | 21 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Delivered as unsterile product | 11,322 | 59.7% |
| Contamination /decontamination problem | 9,719 | 51.3% |
| Device contamination with chemical or other material | 5,776 | 30.5% |
| Unsealed device packaging | 807 | 4.3% |
| Device damaged prior to usethe device was damaged before use | 615 | 3.2% |
| Packaging problem | 520 | 2.7% |
| Tear, rip or hole in device packaging | 404 | 2.1% |
| Difficult to removethe device was hard to remove | 403 | 2.1% |
| Loss of or failure to bond | 168 | 0.9% |
| Device damaged prior to receipt by user | 166 | 0.9% |
| Device contaminated during manufacture or shipping | 162 | 0.9% |
| Material disintegration | 131 | 0.7% |
| Nonstandard device | 131 | 0.7% |
| Insufficient device problem information | 122 | 0.6% |
| Failure to adhere or bond | 84 | 0.4% |
| Material integrity problema problem with the device material | 71 | 0.4% |
| Device operates differently than expectedthe device behaved unexpectedly | 53 | 0.3% |
| Material separation | 29 | 0.2% |
| Difficult to open or remove packaging material | 23 | 0.1% |
| Patient-device incompatibilitythe device did not suit the patient | 20 | 0.1% |
Questions about dressing, wound, occlusive reports
What is product code NAD?
FDA's classification code for "Dressing, wound, occlusive", class 1, reviewed by the general, Plastic Surgery panel. Every device report carries the product code of the device involved.
How many reports carry this code?
18,954 reports through August 2026, 5,587 of them in the latest 12 months.
Which brands appear most often?
Duoderm (10,757), Duoderm/Granuflex/Duoactive - Moisture Retentive Duoderm Cgf Dressing (6,189), L3w0750 - Duoderm (293), Aquacel Foam (12) and Equate (3). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.